Stoke Therapeutics, Inc.

TD ASSET MANAGEMENT INC STOK

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/11/2026

Shares

74,400

Value ($000)

2,422

Weight

0.0%

2019 Q4 - 2026 Q1 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/11/2026	2,422	0.0%	74,400	3/31/2026
2023 Q2	8/9/2023	278	0.0%	26,186	6/30/2023
2023 Q1	5/10/2023	218	0.0%	26,186	3/31/2023
2022 Q4	2/7/2023	242	0.0%	26,186	12/31/2022
2022 Q3	11/7/2022	341	0.0%	26,186	9/30/2022
2022 Q2	8/4/2022	459	0.0%	34,714	6/30/2022
2022 Q1	5/10/2022	731	0.0%	34,714	3/31/2022
2021 Q4	2/10/2022	833	0.0%	34,714	12/31/2021
2021 Q3	11/9/2021	741	0.0%	29,114	9/30/2021
2021 Q2	8/11/2021	834	0.0%	29,114	6/30/2021
2021 Q1	5/14/2021	1,438	0.0%	37,014	3/31/2021
2020 Q4	2/16/2021	1,941	0.0%	31,341	12/31/2020
2020 Q3	11/10/2020	746	0.0%	22,279	9/30/2020
2020 Q2	8/13/2020	531	0.0%	22,279	6/30/2020
2020 Q1	5/15/2020	510	0.0%	22,279	3/31/2020
2019 Q4	2/11/2020	563	0.0%	19,879	12/31/2019